EDGAR Filing Documents for 0001493152-15-001884

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001493152-15-001884

Filing Date

2015-05-13

Accepted

2015-05-13 09:03:16

Documents

Period of Report

2015-03-31

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form10-q.htm	10-Q	478103
2		ex31-1.htm	EX-31.1	16014
3		ex32-1.htm	EX-32.1	6090
	Complete submission text file	0001493152-15-001884.txt		4362723

Data Files

Seq	Description	Document	Type	Size
4	XBRL INSTANCE FILE	lixt-20150331.xml	EX-101.INS	521206
5	XBRL SCHEMA FILE	lixt-20150331.xsd	EX-101.SCH	57677
6	XBRL CALCULATION FILE	lixt-20150331_cal.xml	EX-101.CAL	34640
7	XBRL DEFINITION FILE	lixt-20150331_def.xml	EX-101.DEF	157941
8	XBRL LABEL FILE	lixt-20150331_lab.xml	EX-101.LAB	352854
9	XBRL PRESENTATION FILE	lixt-20150331_pre.xml	EX-101.PRE	224025

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733

Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 15856590
SIC: 2834 Pharmaceutical Preparations